Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
May 9, 2006
[Application of Excel Visual Basic for efficiently complete statistic analysis]
Xu-Hong Hou, Fu-Jie Shen, Jian-Hua Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 24, 2004
[Epidemiology of communicable diseases in Huangpu District, Shanghai City, 1996--2002]
Jian-jun Zhou, Fu-jie Shen, Juan-min Ren, et al.
BMC Bioinformatics
|
August 28, 2024
Prediction of mutation-induced protein stability changes based on the geometric representations learned by a self-supervised method
Shan Shan Li, Zhao Ming Liu, Jiao Li, et al.
Science (New York, N.Y.)
|
September 26, 2024
Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation
Yu Liang, Shuai Shao, Xin Yu Li, et al.
Biochemical and Biophysical Research Communications
|
May 22, 2026
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines
Shuai Shao, Ze Yuan Dong, Zi Yao Kang, et al.
Elife
|
August 25, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Jing Zhang, Zi Bo Han, Yu Liang, et al.
Cell Discovery
|
February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
May 9, 2006
[Application of Excel Visual Basic for efficiently complete statistic analysis]
Xu-Hong Hou, Fu-Jie Shen, Jian-Hua Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 24, 2004
[Epidemiology of communicable diseases in Huangpu District, Shanghai City, 1996--2002]
Jian-jun Zhou, Fu-jie Shen, Juan-min Ren, et al.
BMC Bioinformatics
|
August 28, 2024
Prediction of mutation-induced protein stability changes based on the geometric representations learned by a self-supervised method
Shan Shan Li, Zhao Ming Liu, Jiao Li, et al.
Science (New York, N.Y.)
|
September 26, 2024
Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation
Yu Liang, Shuai Shao, Xin Yu Li, et al.
Biochemical and Biophysical Research Communications
|
May 22, 2026
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines
Shuai Shao, Ze Yuan Dong, Zi Yao Kang, et al.
Elife
|
August 25, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Jing Zhang, Zi Bo Han, Yu Liang, et al.
Cell Discovery
|
February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Page
of 1